Affinity Biosensors Overview
- Founded
-
2006
- Status
-
Private
- Employees
-
23
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$3.71M
- Investors
-
4
Affinity Biosensors General Information
Description
Developer of an antimicrobial susceptibility testing device designed to provide a rapid way to measure and observe growth and response. The company's device can be used for cell counting, and visual observation of liquid samples, helping healthcare professionals in the measurement of mass in fluid, with femtogram resolution, and detecting positive growth.
Contact Information
Website
www.affinitybio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Primary Office
- 222 East Canon Perdido Street
- Suite 101
- Santa Barbara, CA 93101
- United States
+1 (860) 000-0000
Affinity Biosensors Timeline
Affinity Biosensors Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC (Series A) | 17-Feb-2023 | $3.71M | 000.00 | Completed | Generating Revenue | |
| 10. Later Stage VC (Series A) | 17-Nov-2021 | 00.00 | 0000 | Completed | Generating Revenue | |
| 9. Later Stage VC (Series A3) | 03-Feb-2020 | 00.000 | 000.00 | Completed | Generating Revenue | |
| 8. Later Stage VC (Series A2) | 17-Dec-2018 | 00.000 | 000.00 | Completed | Generating Revenue | |
| 7. Later Stage VC (Series A2) | 23-Aug-2016 | 00.000 | 000.00 | Completed | Generating Revenue | |
| 6. Later Stage VC (Series A2) | 09-Feb-2015 | 000 | 00.000 | Completed | Generating Revenue | |
| 5. Later Stage VC (Series B) | 23-Dec-2013 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 4. Later Stage VC | 19-Jul-2011 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 3. Grant | 01-Jan-2009 | $899K | $300K | Completed | Generating Revenue | |
| 2. Angel (individual) | 03-Apr-2008 | $300K | $300K | Completed | Generating Revenue |
Affinity Biosensors Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of an antimicrobial susceptibility testing device designed to provide a rapid way to measure and observe growt
Diagnostic Equipment
Santa Barbara, CA
23
As of 2023
000.00
00000000000
000.00
000000
rehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excep
0000000000 000000000
Depew, NY
000
As of 0000
0000
0000-00-00
000000&0
000000
por incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis n
0000000000 000000000
Martinsried, Germany
00
As of 0000
000.00
000000 0
000.00
Add Comparison
Affinity Biosensors Competitors (2)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Reichert | Formerly PE-Backed | Depew, NY | 000 | 000000&0 | ||
| 0000000 0000000000 | Venture Capital-Backed | Martinsried, Germany | 00 | 000.00 | 000000 0 | 000.00 |
Affinity Biosensors Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Affinity Biosensors Patents
Affinity Biosensors Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3044566-B1 | Measurement of cell growth and drug susceptiblity by resonant mass measurement | Active | 09-Sep-2013 | 00000000000 | |
| EP-3044566-A2 | Measurement of cell growth and drug susceptiblity by resonant mass measurement | Active | 09-Sep-2013 | 00000000000 | |
| US-9835614-B2 | Measurement of cell growth and drug susceptibility by resonant mass measurement | Active | 09-Sep-2013 | 00000000000 | |
| US-20150072373-A1 | Measurement of cell growth and drug susceptibility by resonant mass measurement | Active | 09-Sep-2013 | 00000000000 | |
| US-20140345369-A1 | System and method for measuring viscosity using particle transit time in resonant microfluidic channels | Inactive | 01-May-2013 | G01N11/10 | 0 |
Affinity Biosensors Executive Team (5)
Affinity Biosensors Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| James Iuliano | Affinity Biosensors | Manager & Board Member | 000 0000 |
| L. Robert Johnson | Affinity Biosensors | Manager & Board Member | 000 0000 |
Affinity Biosensors Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Affinity Biosensors Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Rose Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Founders Capital Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| National Institute of Standards and Technology | Government | 000 0000 | 000000 0 | ||
| National Science Foundation | Government | 000 0000 | 000000 0 |
Affinity Biosensors Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 | 16-Jun-2018 | 00000 0000 | 00.000 | Biotechnology | |
| Travera | 20-Feb-2018 | Early Stage VC | 00000 | Biotechnology |